Myelofibrosis-Induced Erythropoietin-Resistant Anemia Due to Severe Refractory Hyperparathyroidism

被引：8
|
作者：
Sethi, Sidharth Kumar [1 ]
Bansal, Shyam Bihari [1 ]
Wadhwani, Nikita [1 ]
Makasana, Mayur [1 ]
Nandwani, Ashish [1 ]
Kher, Vijay [1 ]
Raina, Rupesh [2 ]
机构：
[1] Medanta, Kidney Inst, Gurgaon, Haryana, India
[2] Akron Childrens Hosp, Pediat Nephrol, 214 W Bowery St, Akron, OH 44308 USA
来源：
KIDNEY INTERNATIONAL REPORTS | 2018年 / 3卷 / 04期
关键词：
BONE-MARROW FIBROSIS; PARATHYROID-HORMONE; CINACALCET; CALCIFICATION; HYPERCALCEMIA; DISEASE;
D O I：
10.1016/j.ekir.2018.04.003
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1010 / 1014
页数：5
相关论文
共 43 条
  • [21] New combination of HIF1-α and corticosteroids offers hope for better treatment of erythropoietin-resistant anemia
    不详
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (01) : 5 - 5
  • [22] Massive bone marrow involvement in an end stage renal failure case with erythropoietin-resistant anemia and primary hyperoxaluria
    Tasli, Funda
    Ozkok, Guliz
    Ok, Ebru Sevinc
    Soyer, Nur
    Mollamehmetoglu, Hulya
    Vardar, Enver
    [J]. RENAL FAILURE, 2013, 35 (08) : 1167 - 1169
  • [23] Cyclosporin-A in severe refractory anemia of myelofibrosis with myeloid metaplasia: a preliminary report
    Centenara, E
    Guarnone, R
    Ippoliti, G
    Barosi, G
    [J]. HAEMATOLOGICA, 1998, 83 (07) : 622 - 626
  • [24] Idiopathic myelofibrosis and direct Coombs' positive anemia: Remission of refractory anemia after treatment with rituximab and evidence that rituximab may revert unresponsiveness to erythropoietin.
    Hasselbalch, HC
    Pedersen, M
    [J]. BLOOD, 2003, 102 (11) : 341B - 341B
  • [25] SERUM ERYTHROPOIETIN LEVELS IN PATIENTS WITH SEVERE ANEMIA SECONDARY TO INFLAMMATORY BOWEL-DISEASE AND THE USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS WITH ANEMIA REFRACTORY TO TREATMENT
    DEMIRTURK, L
    HULAGU, S
    YAYLACI, M
    ALTIN, M
    OZEL, M
    [J]. DISEASES OF THE COLON & RECTUM, 1995, 38 (08) : 896 - 897
  • [26] Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet
    Apostolou, T.
    Damianou, L.
    Kotsiev, V.
    Drakopoulos, S.
    Hadjiconstantinou, V.
    [J]. CLINICAL NEPHROLOGY, 2006, 65 (05) : 374 - 377
  • [27] Short-term effect of low-dose roxadustat combined with erythropoiesis-stimulating agent treatment for erythropoietin-resistant anemia in patients undergoing maintenance hemodialysis
    Xu, Qiaoying
    Huang, Jingjing
    Liu, Qingzhen
    Wang, Xueling
    Liu, Haiying
    Song, Yan
    Dou, Fulin
    Lv, Shasha
    Liu, Gang
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [28] Plasmodium Products Contribute to Severe Malarial Anemia by Inhibiting Erythropoietin-Induced Proliferation of Erythroid Precursors
    Thawani, Neeta
    Tam, Mifong
    Bellemare, Marie-Josee
    Bohle, D. Scott
    Olivier, Martin
    de Souza, J. Brian
    Stevenson, Mary M.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (01): : 140 - 149
  • [29] Severe drug-induced immune hemolytic anemia due to cefmetazole: A case report
    Fukuda, Masafumi
    Nabeta, Masakazu
    Oya, Shuki
    Takasu, Osamu
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2022, 60 (01) : 52 - 56
  • [30] Refractory hemolytic anemia due to severe swirling flow pattern in chronic mitral regurgitation after myxoma surgery
    Kurt, Ibrahim Halil
    Baysan, Oben
    Korkmaz, Levent
    Uysal, Onur Kadir
    [J]. ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2012, 12 (07): : 600 - 601
12345